Just Released: "NeuroMEDx - Product Pipeline Analysis."
NeuroMEDx develops technologies for treating neurological disorders. It carries out diagnosis and treatment for parkinson's, migrane, essential tremor, epilepsy, obesity, and incontinence. The company implants mechanoelectric devices (MEDs) on targeted tissues in order to modify their physiologic properties and function by therapeutically. The implant takes place through MRI and CAT methods. MEDs are expected to provide controlled treatment without the peripheral damage, and side effects during pre-clinical evaluation. It owns three US patents: 7,300,449, 6,764,498, and 6,375,666, while some other...
View full press release